Obesity Flashcards

(29 cards)

1
Q

How is obesity defined?

A

A chronic, progressive, relapsing, multifactorial, neurobehavioral disease in which excess body fat causes adipose tissue dysfunction and abnormal physical forces, leading to adverse metabolic, biomechanical, and psychosocial health consequences.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the key diagnostic criteria for obesity?

A
  • Excessive body fat as measured by reliable methods
  • Caused by genetic, developmental, environmental, or medical factors
  • Leads to structural or functional abnormalities increasing morbidity and mortality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is adiposopathy?

A

Dysfunction of adipose tissue endocrine and immune function leading to metabolic disease (“sick fat disease”).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is fat mass disease?

A

Physical stress or damage caused by excessive fat mass on other body tissues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Are the health effects of obesity just co-morbidities or risk factors?

A

No — they are direct adverse consequences of excess body fat.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is BMI calculated?

A

BMI = weight (kg) ÷ height (m²)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are advantages of using BMI?

A
  • Correlates with metabolic and fat mass disease in populations
  • Commonly used, reproducible, low cost
  • Adequate for epidemiological studies and general screening
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are disadvantages of using BMI?

A
  • May not correlate with disease in individuals
  • Does not account for muscle mass
  • Same cutoffs for all sexes and ethnicities
  • Should not be the sole measure of obesity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What key aspects should be covered in the history of an obese patient?

A
  • Medication history
  • Family history
  • Socioeconomic and cultural background
  • Nutritional intake and eating behavior (food diary)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What should be assessed on physical examination?

A
  • Vital signs - height, weight, waist circumference, BP, pulse
  • General physical examination for comorbidities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What defines a very low-calorie diet (VLCD)?

A

Less than 800 kcal/day, using formulated meal replacements under medical supervision.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do VLCDs compare to standard low-calorie diets?

A

Cause more rapid weight loss due to lower energy intake.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What metabolic improvements can VLCDs produce?

A
  • Reduced fasting glucose, insulin, triglycerides
  • Modest increase in HDL
  • Modest decrease in LDL
  • Reduced blood pressure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are risks of VLCDs?

A

Fatigue, nausea, constipation, diarrhoea, cold intolerance, increased gallstones, and possible weight regain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What must be assessed before starting an exercise program?

A
  • Current activity level
  • Readiness to exercise
  • Patient expectations and goals
  • Need for medical testing
  • Formal exercise prescription (FITTTE: Frequency, Intensity, Time, Type, Training, Enjoyment)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the 5 A’s of obesity management?

A
  1. Ask – permission to discuss weight
  2. Assess – BMI, waist circumference, obesity stage
  3. Advise – on health risks and long-term strategies
  4. Agree – on realistic goals and behavioral changes
  5. Arrange/Assist – address barriers, provide resources, follow-up
17
Q

What class of medication is Orlistat?

A

Gastrointestinal lipase inhibitor.

18
Q

What is Orlistat’s mechanism of action?

A

Impairs gastrointestinal fat absorption.

19
Q

What are potential adverse effects of Orlistat?

A
  • Oily rectal discharge
  • Flatus with discharge
  • Increased defecation
  • Fecal incontinence
  • Gallstone risk
  • Urinary oxalate risk
  • Rare liver injury
  • Reduced absorption of fat-soluble vitamins (A, D, E, K)
20
Q

What class of drug is Liraglutide?

A

GLP-1 (glucagon-like peptide-1) receptor agonist.

21
Q

How is Liraglutide administered?

A

Subcutaneous injection via prefilled multi-dose pen.

22
Q

What is the recommended maintenance dose of Liraglutide for obesity?

A

3 mg daily, at any time of day, regardless of meals.

23
Q

What is the Liraglutide dose escalation schedule?

A
  • Week 1 - 0.6 mg/day
  • Week 2 - 1.2 mg/day
  • Week 3 - 1.8 mg/day
  • Week 4+ - 3 mg/day
24
Q

When should bariatric surgery be considered?

A

In potential candidates with severe obesity, after multidisciplinary assessment and failure of conservative therapy (specific criteria not provided in notes).

25
What is the most optimal bariatric procedure to perform?
Vertical sleeve gastrectomy.
26
What are the two main disease mechanisms of obesity?
1. Adiposopathy (“sick fat”) – endocrine and immune dysfunction of adipose tissue. 2. Fat mass disease – physical/mechanical stress from excessive body fat.
27
What are some contributing factors to obesity?
Genetic/developmental errors, infections, hypothalamic injury, medications, energy imbalance, and environmental factors.
28
What are the metabolic, biomechanical, and psychosocial consequences of obesity?
- Increased morbidity and mortality due to metabolic syndrome - joint disease - mental health burden.
29
What is the primary goal of obesity treatment?
Long-term weight management through combined nutritional, behavioral, pharmacological, and surgical strategies.